Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds GDBYF.
No tracked institution reports a position in GDBYF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2022-08-26 | 1-for-10reverse |
No one on the platform has traded GDBYF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$GDBYF [15s. delayed]: Issued Press Release on January 31, 08:00:00: Goodbody Health Progress Update: Phlebotomy Services https://s.flashalert.me/2W3QjM
View on StockTwits ↗$GDBYF Goodbody Health Progress Update: Phlebotomy Services https://www.stocktitan.net/news/GDBYF/goodbody-health-progress-update-phlebotomy-6lyxg1wqd79c.html
View on StockTwits ↗$GDBYF [15s. delayed]: Issued Press Release on January 26, 08:00:00: Goodbody Health Partners with Datar to Offer Innovative Cancer Screen https://s.flashalert.me/JbcIH
View on StockTwits ↗$GDBYF Goodbody Health Partners with Datar to Offer Innovative Cancer Screening https://www.stocktitan.net/news/GDBYF/goodbody-health-partners-with-datar-to-offer-innovative-cancer-k3ikwnfgthof.html #cancer
View on StockTwits ↗$GDBYF [15s. delayed]: Issued Press Release on December 29, 19:01:00: Board Updates https://s.flashalert.me/6Ho5to
View on StockTwits ↗$GDBYF Board Updates https://www.stocktitan.net/news/GDBYF/board-iy9h6jgngs7b.html
View on StockTwits ↗$GDBYF [15s. delayed]: Issued Press Release on December 16, 07:01:00: Goodbody Health Announces Cash Injection for Growth Through Divestme https://s.flashalert.me/zP7Ynd
View on StockTwits ↗$GDBYF Goodbody Health Announces Cash Injection for Growth Through Divestment of Polish CBD Operations https://www.stocktitan.net/news/GDBYF/goodbody-health-announces-cash-injection-for-growth-through-gjemt90pxdug.html
View on StockTwits ↗$GDBYF Read a quick update on Goodbody by our credible analysts: 1. Its Q3 revenue was down 62% YoY, 16% QoQ, beating our analyst's estimate by 14%. EPS was 6% higher than estimates. 2. GDBY conducted 25k tests in Q3, down 17% QoQ. Although segmented results were not disclosed, our analysts believe that the company's new blood testing services have started gaining traction. 3. Company was able to lower G&A expenses by 22% QoQ in Q3, by cutting staff and professional expenses. Find out if our analysts are raising or lowering their GDBY revenue forecasts for 2023 here: https://www.researchfrc.com/goodbody-health-limited-otcqb-gdbyf-aqse-gdby-gaining-traction-for-new-services/ 👉Question of the day: A lot of people were investing in the healthcare sector during COVID. Do you think it's a good bet? Let us know in the comments down below! ⬇️ *FRC provides issuer-paid coverage. *Past performance is not indicative of future results.
View on StockTwits ↗$GDBYF Board Update https://www.stocktitan.net/news/GDBYF/board-iec5grhqv3eg.html
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.